KMT2A and acute myeloid leukemia: These genetically modified GFP+ cells were subsequently sorted and transplanted into lethally irradiated syngeneic recipients to generate MLL-AF9-induced Rheb1fl/fl or Rheb1Δ/Δ AML mice, respectively.